Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Hyperglycemia Post-Influenza Vaccine in Patients With Diabetes
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Hyperglycemia Post-Influenza Vaccine in Patients With Diabetes'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Hyperglycemia
100%
Patients with Diabetes
100%
Influenza Vaccine
100%
Revaccination
85%
Blood Glucose
42%
Hispanic
14%
Texas
14%
Fasting Plasma Glucose
14%
Hemoglobin A1c (HbA1c)
14%
San Antonio
14%
Type 1 Diabetes Mellitus (T1DM)
14%
Vaccination
14%
Median Value
14%
Trivalent Influenza Vaccine
14%
Return-to-baseline
14%
Intramuscularly
14%
Counseling
14%
Vaccination Rate
14%
Influenza Season
14%
Multicenter Cohort Study
14%
Potential Gap
14%
Reporting System
14%
Flu Vaccine
14%
Transient Property
14%
Medication Changes
14%
Pre-vaccination
14%
Vaccine Adverse Events
14%
Medicine and Dentistry
Hyperglycemia
100%
Patient with Diabetes
100%
Influenza Vaccine
100%
Blood Glucose
42%
Diabetes Mellitus
14%
Adverse Event
14%
Counseling
14%
Single Drug Dose
14%
Drug Therapy
14%
Prospective Cohort Study
14%
Hemoglobin A1c
14%
Nursing and Health Professions
Patient with Diabetes
100%
Hyperglycemia
100%
Influenza Vaccine
100%
Glucose Blood Level
42%
Drug Therapy
14%
Adverse Event
14%
Diabetes Mellitus
14%
Prospective Cohort Study
14%
Counseling
14%
Hemoglobin A1c
14%
Single Drug Dose
14%
Immunology and Microbiology
Influenza Vaccine
100%
Glucose Blood Level
60%
Influenza
20%
Veterinary Science and Veterinary Medicine
Influenza Vaccine
100%
Live Attenuated Influenza Vaccine
20%